News for 'Food and Drug Control Administration'

Lupin acquires US generics firm GAVIS for $880 mn

Lupin acquires US generics firm GAVIS for $880 mn

Rediff.com24 Jul 2015

Lupin will fund the buy through $100 mn cash reserves and a bridge loan.

Profit might be hit in FY16: Sun Pharma

Profit might be hit in FY16: Sun Pharma

Rediff.com21 Jul 2015

4 Ranbaxy facilities in India have been barred from exporting to US.

Ray of hope? Jaipur's 'safe' lab might redo Maggi study

Ray of hope? Jaipur's 'safe' lab might redo Maggi study

Rediff.com14 Aug 2015

The lab has 18 scientists.

Trump again calls coronavirus as 'China Virus'

Trump again calls coronavirus as 'China Virus'

Rediff.com25 Aug 2020

In March, he had said that China is responsible for the spread of the novel coronavirus and called the COVID-19 as the "Chinese Virus".

Moderna says its COVID-19 vaccine is 94.5% effective

Moderna says its COVID-19 vaccine is 94.5% effective

Rediff.com16 Nov 2020

Cambridge, Massachusetts-based Moderna's announcement comes just a week after Pfizer and Biontech said their COVID-19 vaccine candidate was found to be more than 90 per cent effective in preventing COVID-19 in participants.

Religare's banking bid under Ranbaxy cloud

Religare's banking bid under Ranbaxy cloud

Rediff.com1 Jun 2013

Singh brothers might be stopped by 'fit & proper' hurdle due to US drug norm violations; firm says confident of qualifying.

3 Indian pharma firms named in US Congress price probe

3 Indian pharma firms named in US Congress price probe

Rediff.com9 Oct 2014

Details on prices sought as 10 generic drugs become up to 83 times costlier in 6 months

Pfizer says its Covid vaccine is 95% effective in final trials

Pfizer says its Covid vaccine is 95% effective in final trials

Rediff.com18 Nov 2020

Pfizer and BioNTech said they have concluded phase 3 study of their mRNA-based COVID-19 vaccine candidate BNT162b2, meeting all primary efficacy endpoints.

Ranbaxy hires BCG, Mercer for internal strategic project

Ranbaxy hires BCG, Mercer for internal strategic project

Rediff.com1 Jun 2013

Consultants are working with various teams on manufacturing, R&D, etc, to assess per-month productivity of each department.

'The government's priorities are all wrong'

'The government's priorities are all wrong'

Rediff.com14 Apr 2020

'The prime minister did not think that COVID-19 was a serious challenge as late as March 20.'

With over 85k cases, US has most Covid cases in world

With over 85k cases, US has most Covid cases in world

Rediff.com27 Mar 2020

Trump attributed the spike in the confirmed cases of coronavirus to the large-scale testing of the deadly disease.

Earning woes drag markets lower; TCS, HUL lead fall

Earning woes drag markets lower; TCS, HUL lead fall

Rediff.com14 Oct 2015

Earning woes drag markets lower; TCS, HUL lead fall.

Pharma in 2014: Deals worth billions and fines worth millions

Pharma in 2014: Deals worth billions and fines worth millions

Rediff.com26 Dec 2014

In a surprise announcement in April, Sun and Ranbaxy -- at that time owned by Japan's Daiichi -- declared an all-stock deal to create India's largest and world's fifth-largest drugmaker in an over $4 billion deal.

Don't need to sell assets, can pay fine: Ranbaxy brothers

Don't need to sell assets, can pay fine: Ranbaxy brothers

Rediff.com25 May 2016

In 2013, Daiichi had launched the arbitration proceedings in Singapore.

Teenagers smoke to lose weight

Teenagers smoke to lose weight

Rediff.com14 Oct 2016

A recent survey revealed that 46 percent of girls and 30 percent of boys in the US, most of who are in their teens smoke to control their weight.

Suspected human hair in tablet cited in Ranbaxy ban

Suspected human hair in tablet cited in Ranbaxy ban

Rediff.com18 Sep 2013

Ranbaxy, which is 63.5 per cent-owned by Japan's Daiichi Sankyo Co and gets more than 40 per cent of its sales from the United States, did not immediately respond to a request on Wednesday for comment on the FDA observations.

2017 begins with a bang for outbound M&A deals

2017 begins with a bang for outbound M&A deals

Rediff.com31 Jan 2017

Indian companies have made acquisitions of $1 billion so far in January

ICMR asks states not to use rapid test kits for 2 days

ICMR asks states not to use rapid test kits for 2 days

Rediff.com21 Apr 2020

"We have received complaint from a state yesterday and so far discussed with three states. Too much variations have been reported in results of rapid test kits and RT-PCR kits. We advise states not to use them for the next two days," ICMR's Dr Raman R Gangakhedkar said.

My worry is whether a child is consuming excessive lead: FSSAI CEO

My worry is whether a child is consuming excessive lead: FSSAI CEO

Rediff.com7 Aug 2015

Maggi noodles was recalled in June because some states had found presence of MSG and excessive lead content in the samples.

Meet the man behind the Sun Pharma-Ranbaxy deal

Meet the man behind the Sun Pharma-Ranbaxy deal

Rediff.com8 Apr 2014

Sun Pharma's offer was tempting because Ranbaxy was too busy fighting fires in the US to concentrate on operations.

'When virus is still circulating, older people are more at risk'

'When virus is still circulating, older people are more at risk'

Rediff.com6 Oct 2021

'We lost our place in being first in the epidemic, when it hit India so hard, but we were actually the epicentre of the epidemic from essentially April 2020, for almost an entire year. We had such high cases. We were the country that had the most mixed response.'

Pharma stocks could rise another 15-20%

Pharma stocks could rise another 15-20%

Rediff.com28 Jul 2014

Expectations of strong results, consistent performance and investors preference for stocks in the defensive space help the sector outshine broader markets.

Indian soldiers use this start-up's smart bandage, but others need it too

Indian soldiers use this start-up's smart bandage, but others need it too

Rediff.com27 Mar 2018

Beside the defence forces in India, the start-up has shipped around 350,000 units to 12 countries -- the United Kingdom, France, Poland, Bangladesh, Saudi Arabia, the UAE, Kenya, South Africa, Romania, Indonesia, Qatar and Oman.

Drugmakers draw more FDA scrutiny as US imports rise

Drugmakers draw more FDA scrutiny as US imports rise

Rediff.com13 Sep 2013

And when an inspector asked about the contents of unlabelled vials in the laboratory glassware washing area, a plant worker dumped them down a sink and said the contents could not be determined, according to a July 18 letter from the US Food and Drug Administration to Wockhardt, which makes sterile injectable drugs and various forms of insulin.

India can deliver COVID-19 vaccine swiftly and efficiently

India can deliver COVID-19 vaccine swiftly and efficiently

Rediff.com4 Jan 2021

'Rolling out the vaccine is not a major challenge in India.'

Dr Reddy's gets warning from US health regulator

Dr Reddy's gets warning from US health regulator

Rediff.com7 Nov 2015

Dr Reddy's gets warning from US health regulator

The big plan: Nestle gearing up for Maggi's comeback

The big plan: Nestle gearing up for Maggi's comeback

Rediff.com19 Jun 2015

Nestle is sure to go for a relaunch of the noodles soon enough with an advertising blitz,

If there are 70,000 cases in May...Mumbai is ready

If there are 70,000 cases in May...Mumbai is ready

Rediff.com2 May 2020

'Our preparation is based on ICMR projections, whatever preparations we have to make.' 'If they project around 70,000 is the maximum number of hospital cases by mid-May or May 30, we are preparing accordingly -- how many people will need hospitalisation.'

Sensex rallies 259 points to end at 2-week high

Sensex rallies 259 points to end at 2-week high

Rediff.com30 Nov 2016

HSBC maintained "overweight" rating on Indian equities, saying "fundamentals are strong".

Nifty ends above 8,700 at fresh 52-week closing high; RBI policy eyed

Nifty ends above 8,700 at fresh 52-week closing high; RBI policy eyed

Rediff.com8 Aug 2016

Gains were led by index heavyweights with Reliance Industries contributing the most.

Why Sunil Munjal is keen to acquire Fortis

Why Sunil Munjal is keen to acquire Fortis

Rediff.com17 Apr 2018

According to Munjal, there is an opportunity for somebody who comes from a not for profit background in health care to do something.

Why India Inc sees Modi's PMO as the 'mover'

Why India Inc sees Modi's PMO as the 'mover'

Rediff.com11 Aug 2017

Corporates understand that the PMO drives all key decisions in this government.

'But who do we blame? Who do we beat up? Doctors!'

'But who do we blame? Who do we beat up? Doctors!'

Rediff.com24 Mar 2017

A resident doctor, working at a government hospital, upset by the poor response from the state government, offers his side of the story.

How Amul is quelling the 'non-veg' rumours

How Amul is quelling the 'non-veg' rumours

Rediff.com21 Sep 2018

This is not the first time Gujarat Cooperative Milk Marketing Federation that owns brand Amul has chosen an unconventional method to protect its brand.

Nifty ends below 7,750 amid volatility; Lupin falls 12% in 2 sessions

Nifty ends below 7,750 amid volatility; Lupin falls 12% in 2 sessions

Rediff.com23 May 2016

Stellar rally in ITC shares along with strength in the Asian equities capped the downside.

Dilip Shanghvi's X factor shows up in different ways

Dilip Shanghvi's X factor shows up in different ways

Rediff.com13 Mar 2015

Dilip Shanghvi has never tried to be everything to everybody.

The A to Z of 2020

The A to Z of 2020

Rediff.com31 Dec 2020

We present our alphabet of 2020, pulling in everything you'll remember about this year we'd rather forget.

Sensex retreats from 1-week high; real estate, banks fall

Sensex retreats from 1-week high; real estate, banks fall

Rediff.com13 Jan 2015

The 30-share Sensex ended down 159 points at 27,425 and the 50-share Nifty closed down 24 points at 8,299.

2018: Year of reckoning for India Inc

2018: Year of reckoning for India Inc

Rediff.com28 Dec 2018

A glance back at some of the important ups and down Indian Inc faced in 2018.

The extraordinary doctor who makes a difference

The extraordinary doctor who makes a difference

Rediff.com14 Aug 2015

Rediff.com digs into its archives, tracking down Dr M R Rajagopal's sincere efforts of changing lives and changing the way India looks at palliative care.